BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10589277)

  • 1. [In situ hybridization techniques. Basis and applications in hematologic neoplasias].
    Espinet B; Lloveras E; Solé F
    Sangre (Barc); 1999 Aug; 44(4):261-7. PubMed ID: 10589277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytogenetic study of 121 patients suffering from various hematologic neoplasms using the in situ hybridization technique].
    Pérez Losada A; Solé F; Woessner S; Florensa L; Besses C; Espinet B; Caballín MR; García Eroles L; Sans-Sabrafén J
    Sangre (Barc); 1996 Jun; 41(3):201-9. PubMed ID: 8755208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative genomic hybridization. Methodologic features].
    García JL; Gutiérrez NC; Hernández JM; Sánchez MA; González MB; Arroyo JL; San Miguel JF
    Sangre (Barc); 1999 Aug; 44(4):291-6. PubMed ID: 10589281
    [No Abstract]   [Full Text] [Related]  

  • 4. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
    Mecucci C; Falzetti D; La Starza R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
    [No Abstract]   [Full Text] [Related]  

  • 5. [Applications of fluorescence in situ hybridization in the study of hematologic neoplasms].
    Hernández JM; Tabernero MD; García JL
    Sangre (Barc); 1996 Aug; 41(4):305-9. PubMed ID: 8984672
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analysis of human oocytes: advantages of a double-labeling procedure.
    Pellestor F; Anahory T; Andréo B; Régnier-Vigouroux G; Soulié JP; Baudouin M; Demaille J
    Fertil Steril; 2004 Oct; 82(4):919-22. PubMed ID: 15482769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonisotopic in situ hybridization. Gene mapping and cytogenetics.
    Bhatt B; Sahinoglu T; Stevens C
    Methods Mol Biol; 1998; 80():405-17. PubMed ID: 9664397
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of short telomeres in inducing preferential chromosomal aberrations in human ovarian surface epithelial cells: A combined telomere quantitative fluorescence in situ hybridization and whole-chromosome painting study.
    Deng W; Tsao SW; Guan XY; Lucas JN; Cheung AL
    Genes Chromosomes Cancer; 2003 May; 37(1):92-7. PubMed ID: 12661010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent duplication of Xq27-qter in hematological malignancies revealed by multicolor fluorescence in situ hybridization and multicolor banding.
    MacKinnon RN; Zordan A; Campbell LJ
    Cancer Genet Cytogenet; 2005 Sep; 161(2):125-9. PubMed ID: 16102582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicolor PRINS and multicolor PNA.
    Pellestor F; Paulasova P; Andréo B; Lefort G; Hamamah S
    Cytogenet Genome Res; 2006; 114(3-4):263-9. PubMed ID: 16954664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One FISH, two FISH, red FISH, blue FISH.
    Le Beau MM
    Nat Genet; 1996 Apr; 12(4):341-4. PubMed ID: 8630478
    [No Abstract]   [Full Text] [Related]  

  • 12. [Applications of fluorescence in situ hybridization (FISH) in acute lymphoblastic leukemia].
    Buades JM; Vizcarra Rabadán E; Sánchez Izquierdo D; Martínez-Climent JA
    Sangre (Barc); 1999 Aug; 44(4):273-81. PubMed ID: 10589279
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
    Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
    Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COmbined Binary RAtio fluorescence in situ hybridiziation (COBRA-FISH): development and applications.
    Raap AK; Tanke HJ
    Cytogenet Genome Res; 2006; 114(3-4):222-6. PubMed ID: 16954657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization.
    Bayani J; Squire JA
    Curr Protoc Cell Biol; 2005 Jan; Chapter 22():Unit 22.6. PubMed ID: 18228467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunology laboratory in malignant blood diseases].
    López Berges MC; Vidriales B; Ocqueteau M; Orfao A
    Sangre (Barc); 1996 Aug; 41(4):281-8. PubMed ID: 8984669
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of fluorescent in-situ hybridisation.
    Jain KK
    Med Device Technol; 2004 May; 15(4):14-7. PubMed ID: 15303557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of chromosome aberrations. In situ hybridization.
    Lichter P; Ried T
    Methods Mol Biol; 1994; 29():449-78. PubMed ID: 8032422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicolor spectral karyotyping (SKY) and its application to the cytogenetic diagnosis of multiple myeloma].
    Cigudosa JC; Calasanz MJ; García Miranda JL
    Sangre (Barc); 1999 Aug; 44(4):301-4. PubMed ID: 10589283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.